Alarum Technologies Ltd. - American Depositary Shares (ALAR)
Live price chart, market sentiment, and community perspectives for Alarum Technologies Ltd. - American Depositary Shares (NASDAQ: ALAR).
Live price chart, market sentiment, and community perspectives for Alarum Technologies Ltd. - American Depositary Shares (NASDAQ: ALAR).
On our desk, evaluating ALAR requires looking past the dramatic 78.9% year-to-date price drop down to $1.81. While the headline figures show a solid Q1 EPS beat of $0.15 versus a $0.01 consensus, sentiment is heavily clouded by multiple pending securities class action lawsuits flagged by firms like Kaplan Fox and Rosen. Institutional and insider ownership remain thin at around 3.23% and 2.70% respectively, creating an atmosphere of heightened caution despite consensus 12-month targets floating significantly higher.
Order flow on ALAR suggests systematic accumulation by long-only institutional accounts during yesterday's dip.
From a quantitative risk perspective, Alarum's short interest has collapsed by over 90% since August 2025 down to just 15.9 thousand shares (0.2% of the float), virtually neutralizing any near-term short squeeze potential. The technical profile remains weak as the American Depositary Shares trade well below the 200-day simple moving average. Market participants must weigh the low short interest and favorable valuation metrics against structural overhangs and regulatory disclosure risks noted in their Form 20-F filings.
When analyzing cross-border equities like Alarum's ADR structure, we always stress understanding the mechanics of foreign private issuers filing Form 20-Fs and Form 6-Ks. Analysts covering ALAR are maintaining a cautious 'hold' consensus rating split among buy, hold, and sell opinions. Anyone assessing this ticker must factor in currency translation implications, potential double taxation aspects of ADRs, and the broader data collection market dynamics highlighted in their forward-looking risk disclosures.
Explore plasma cleansing, somatic organ swaps, and BCI.